Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2023 Earnings Call Transcript

Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2023 Earnings Call Transcript August 9, 2023

Lumos Pharma, Inc. misses on earnings expectations. Reported EPS is $-1.09 EPS, expectations were $-1.06.

Operator: Good afternoon, and welcome to Lumos Pharma’s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I’ll...